Phase I study of ABBV383, a novel BCMAxCD3 bispecific antibody, in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:50 2 years ago 51 Далее Скачать
Phase I study of ABBV-383, a BCMA×CD3 bispecific antibody, in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:14 1 year ago 113 Далее Скачать
Phase I trial of a BCMA-CD3 bispecific antibody in R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:20 4 years ago 149 Далее Скачать
Updated safety and efficacy results of Abbv-383, a novel BsAb, in patients with R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:23 1 year ago 222 Далее Скачать
Phase I study of forimtamig, a GPRC5DxCD3 bispecific antibody, in R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 6:13 2 years ago 207 Далее Скачать
REGN5458, a BCMAxCD3 Bispecific Monoclonal Antibody, in a Phase 1/2 1st-in-Human Study in RRMM Pts International Myeloma Foundation 7:26 3 years ago 577 Далее Скачать
How can the unique structure of the bispecific ABBV-383 impact its safety and efficacy? Multiple Myeloma Hub 4:57 2 years ago 296 Далее Скачать
Cevostamab (BFCR4350A): a novel bispecific antibody in R/R myeloma therapy VJHemOnc – Video Journal of Hematology & HemOnc 1:56 3 years ago 95 Далее Скачать
ASH23: Abbv-383 BCMA x CD3 Bispecific Antibody for Relapsed/Refractory Myeloma | Ravi Vij, MD, MBA International Myeloma Foundation 7:44 1 year ago 249 Далее Скачать
Phase I study of teclistamab, a humanized BCMA x CD3 bispecific antibody, in relapsed/refractory MM International Myeloma Foundation 3:44 4 years ago 704 Далее Скачать
Insights into the Phase III CERVINO trial: ABBV-383 for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:27 3 months ago 94 Далее Скачать
SC vs. IV administration of a BCMA-CD3 bispecific antibody for R/R myeloma VJHemOnc – Video Journal of Hematology & HemOnc 3:30 4 years ago 133 Далее Скачать
ABBV-383 - Upcoming Myeloma Treatment HealthTree University for Multiple Myeloma 19:49 1 year ago 979 Далее Скачать
Efficacy, Safety, and Determination of ABBV-383, a BCMA Bispecific Antibody, in Patients with RRMM International Myeloma Foundation 6:43 6 months ago 260 Далее Скачать
Updated Safety and Efficacy Results of Abbv-383 | Ravi Vij, MD, MBA | ASH 2023 HealthTree Foundation for Multiple Myeloma 3:22 1 year ago 153 Далее Скачать
Novel targets in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:48 3 years ago 76 Далее Скачать
Bispecific BCMA-CD3 antibody teclistamab is efficacious and tolerable in R/R MM VJHemOnc – Video Journal of Hematology & HemOnc 1:29 4 years ago 88 Далее Скачать
What should myeloma patients know about bispecific antibodies? International Myeloma Foundation 3:25 2 years ago 2 232 Далее Скачать
The advent of bispecific antibodies for multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:45 2 years ago 108 Далее Скачать
Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 23:13 1 year ago 4 262 Далее Скачать
